Press Releases on August 12, 2024 - EIN Presswire - Press Release Distribution Service

Published on August 12, 2024 - 12:30 GMT

Stran & Company Reports Preliminary Selected Unaudited Results for the Six Months Ended June 30, 2024

Revenue expected to grow approximately 10% compared to the first six months of 2023 Gross margin expected to increase to 31.7% for the first six months of 2024 vs. 29.4% for the first six months of 2023 Cash, cash equivalents and investments expected to …

Distribution channels: Environment, Retail ...

Published on August 12, 2024 - 12:30 GMT

Oragenics, Inc. Announces Concussion Drug Successfully Completes FDA-Required Genotoxicity Study

– ONP-002 showed no cancer-causing DNA damage – Phase II clinical trial being planned SARASOTA, Fla., Aug. 12, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a company focused on developing unique, intranasal pharmaceuticals for the …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on August 12, 2024 - 12:30 GMT

Bird Continues to Grow Industrial Portfolio Nationally

MISSISSAUGA, Ontario, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Bird Construction Inc. (TSX: BDT) is pleased to announce that it has been selected for five projects with a total combined value exceeding $575 million. These projects include civil site works and …

Distribution channels: Consumer Goods, Media, Advertising & PR ...

Published on August 12, 2024 - 12:30 GMT

Atossa Therapeutics Announces Second Quarter 2024 Financial Results and Provides Corporate Update

Presented data showing 100% disease control rate after 24-week treatment with (Z)-Endoxifen in 40mg cohort of Phase 2 EVANGELINE study at the American Association for Cancer Research (AACR) Annual Meeting Completed enrollment in 80mg PK Run-in Cohort for …

Distribution channels:

Published on August 12, 2024 - 12:30 GMT

Aprea Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

Enrollment commenced in the ACESOT-1051 Phase 1 trial evaluating APR-1051 – no myelosuppression observed in the first of eight planned cohorts at sub-therapeutic dose $28.7 million in cash and cash equivalents as of June 30, 2024 with cash runway extended …

Distribution channels:

Published on August 12, 2024 - 12:30 GMT

SHEIN Transformed Guests into Festival Trendsetters at VELD and îLESONIQ

Toronto, Aug. 12, 2024 (GLOBE NEWSWIRE) -- SHEIN, the global online fashion and lifestyle retailer, concluded its highly successful pop-ups at the VELD and îLESONIQ music festivals this summer, captivating over 10,000 attendees in a vibrant, bubble-themed …

Distribution channels: Culture, Society & Lifestyle, Media, Advertising & PR ...

Published on August 12, 2024 - 12:30 GMT

CytoDyn Announces Completion of FDA Meeting on Phase II Study of Leronlimab in Patients with Relapsed/Refractory Microsatellite ...

VANCOUVER, Washington, Aug. 12, 2024 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...

Published on August 12, 2024 - 12:30 GMT

ConnectM Publishes Impact Scorecard for the Six Months Ended June 30, 2024

~ Cumulative Electrification of 87 GWh Compared to 29 GWh in 1H23 ~ ~ Significant Growth of Electrified Assets Validates Technology of Energy Intelligence Network ~ MARLBOROUGH, Mass., Aug. 12, 2024 (GLOBE NEWSWIRE) -- ConnectM Technology Solutions, Inc. ( …

Distribution channels: Energy Industry, Media, Advertising & PR ...

Published on August 12, 2024 - 12:30 GMT

Telomir Pharmaceuticals Mourns the Passing of Chairman and CEO Dr. Christopher Chapman

Telomir Board of Directors appoints Erez Aminov as CEO and Chairman of the Board Telomir also announces Board of Directors departures and additions TAMPA, Fla., Aug. 12, 2024 (GLOBE NEWSWIRE) -- Telomir Pharmaceuticals, Inc. (Nasdaq: TELO) (“Telomir” or …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on August 12, 2024 - 12:30 GMT

Above Food to Participate in the 44th Annual Canaccord Genuity Growth Conference

REGINA, Saskatchewan, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Above Food Ingredients Inc. (Nasdaq: ABVE, ABVE.W) (“Above Food” or the “Company”), an innovative food company leveraging its vertically integrated supply chain to deliver differentiated ingredients …

Distribution channels:

Published on August 12, 2024 - 12:30 GMT

SRM Expands Distribution with ICEE Brand Sip With Me Cups Coming Soon to a Theater Near You

JUPITER, FL, Aug. 12, 2024 (GLOBE NEWSWIRE) -- SRM Entertainment, Inc., (Nasdaq: SRM) (the “Company” or “SRM”) is pleased to announce new orders and expanded distribution of our custom designed ICEE brand Sip With Me drink cups. The nostalgic ICEE Sip With …

Distribution channels: Consumer Goods ...

Published on August 12, 2024 - 12:30 GMT

OMNIQ Expands AI Access Control System to an Additional Major Medical Center in Texas

Following the recent deployment in Ohio Incorporates new features such as restricted access areas Creates subscription-based revenue for omniQ SALT LAKE CITY, Aug. 12, 2024 (GLOBE NEWSWIRE) -- OMNIQ Corp. (OTCQB: OMQS), a leading provider of Artificial …

Distribution channels: Media, Advertising & PR, Technology ...

Published on August 12, 2024 - 12:30 GMT

Xenon Expands Leadership Team with Matthew D. Ronsheim, Ph.D. as Chief Operating Officer

VANCOUVER, British Columbia and BOSTON, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for …

Distribution channels:

Published on August 12, 2024 - 12:30 GMT

Safety Shot Announces Powerful Data Analysis From Recent Clinical Trial Confirming Dramatic Reduction of Blood Alcohol Content

First-of-its-kind wellness company Safety Shot announces clinical trials solidifying the brand’s dietary supplement’s ability to significantly reduce Blood Alcohol Content JUPITER, FL, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT) (the …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on August 12, 2024 - 12:30 GMT

Wave Life Sciences Receives FDA Rare Pediatric Disease Designation for WVE-N531 for the Treatment of Duchenne Muscular Dystrophy

Designation highlights significant unmet needs in DMD; dystrophin data from potentially registrational FORWARD-53 trial of WVE-N531 are on track for 3Q 2024 In previous Part A trial, WVE-N531 achieved industry-leading exon skipping of 53% and muscle tissue …

Distribution channels: Technology ...

Published on August 12, 2024 - 12:30 GMT

S&P 500 Nuclear Energy Stocks Prices Surge 800% on Largest U.S. Power Grid

LOS ANGELES, CA, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Worldwide Energy Shortages and Soaring Prices are Driving Nuclear Power Growth for US Nuclear Corp. (OTC-QB: UCLE). Extreme weather, soaring energy prices, and outdated energy infrastructure are leaving …

Distribution channels: Aviation & Aerospace Industry ...

Published on August 12, 2024 - 12:30 GMT

Safe and Green Holdings Announces Preliminary Term Sheet to Refinance Waldron Facility

MIAMI, FL, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Safe & Green Holdings Corp. (NASDAQ: SGBX) (“Safe & Green Holdings” or the “Company”), a leading developer, designer, and fabricator of modular structures, today announced that it has received a term …

Distribution channels: Building & Construction Industry, Environment ...

Published on August 12, 2024 - 12:30 GMT

Complete Solaria to Report Second Quarter Financial and Operational Results on August 14, 2024

LEHI, Utah, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Complete Solaria, Inc. (“Complete Solaria” or the “Company”) (Nasdaq: CSLR), a solar technology, services, and installation company, today announced the Company will release its financial and operational …

Distribution channels: Consumer Goods, Culture, Society & Lifestyle ...

Published on August 12, 2024 - 12:30 GMT

DeFi Technologies Subsidiary Valour Inc. Announces Rebalancing of the Valour Digital Asset Basket 10 (VDAB10) and the STOXX ...

TORONTO, Aug. 12, 2024 (GLOBE NEWSWIRE) -- DeFi Technologies Inc. (the “Company” or “DeFi Technologies”) (CBOE CA: DEFI) (GR: R9B) (OTC: DEFTF), a financial technology company that pioneers the convergence of traditional capital markets with the world of …

Distribution channels: Banking, Finance & Investment Industry, Media, Advertising & PR ...

Published on August 12, 2024 - 12:30 GMT

Alarum to Release Second Quarter Results on August 26, 2024

The Company Will Host a Conference Call on Monday, August 26, 2024 at 8:30 a.m. ET Tel Aviv, Israel, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Alarum Technologies Ltd. (Nasdaq, TASE: ALAR) (“Alarum” or the “Company”), a global provider of internet access and web …

Distribution channels: IT Industry ...